“Randomized Controlled Trial of Rivaroxaban Plus Dual Antiplatelet Therapy Versus Dual Antiplatelet Therapy Alone for Prevention of Left Ventricular Thrombus Formation After Acute Myocardial Infarction”. 2025. Pakistan Journal of Medical & Cardiological Review 4 (4): 2832-40. https://doi.org/10.66021/pakmcr1119.